CSI Market
Sign In | Register

Ideaya Biosciences Inc (IDYA) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access IDYA quarterly Cash Flow →
Looking at cash flow data from Ideaya Biosciences Inc through Dec 31 2021 provides insight into Dec 31 2025's financial flexibility across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-113.70
Depreciation & amortization2.70
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation46.12
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Change In Fair Value Of Redeemable Convertible Preferred Stock Liability-
Increase Decrease In Operating Lease Right Of Use Assets-
Increase Decrease In Contract With Customer Liability-
Increase Decrease In Contract With Customer Asset And Liabilities-5.97
Operating Lease Right Of Use Asset Amortization Expense1.89
Income taxes0.00
Gain on Sale of Investments0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable2.70
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities10.43
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-7.84
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-7.42
Discontinued operations0.00
Net Cash flow from Operating Activities-71.10
Investing Activities
Capital Expenditures-2.37
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities680.23
Payments to Acquire Available-for-sale Securities, Debt-607.89
Real Estate Investments0.00
Proceeds From Maturity Of Marketable Securities-
Proceeds From Sale Of Marketable Securities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities69.98
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock4.92
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-86.20
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents85.18
Restricted Cash1.02
Proceeds From Issuance Of Common Stock Related To At Market Offering Program Net Of Issuance Costs24.86
Proceeds From Issuance Of Common Stock At The Market Offering Program Net Of Issuance Cost-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities29.78
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-73.47
Total Cash Flow28.66
4 historic quarters locked

Sign in to unlock the full Ideaya Biosciences Inc cash flow history.

Sign In Create Free Account

About Ideaya Biosciences Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 17, 2026
  • Source: idya-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-054533

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License